ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

ClinicalTrials.gov ID: NCT02504216

Public ClinicalTrials.gov record NCT02504216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures

Study identification

NCT ID
NCT02504216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
6,564 participants

Conditions and interventions

Interventions

  • Rivaroxaban (Xarelto, BAY59-7939) Drug
  • Rivaroxaban-Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2015
Primary completion
Nov 26, 2019
Completion
Jan 8, 2020
Last update posted
Dec 7, 2020

2015 – 2020

United States locations

U.S. sites
105
U.S. states
32
U.S. cities
94
Facility City State ZIP Site status
Not listed Alexander City Alabama 35010
Not listed Birmingham Alabama 35294-0012
Not listed Fort Payne Alabama 35967
Not listed Huntsville Alabama 35801-4317
Not listed Avondale Arizona 85388
Not listed Glendale Arizona 85340
Not listed Phoenix Arizona 85006
Not listed Mission Viejo California 92691
Not listed Northridge California 91325
Not listed Palo Alto California 94304
Not listed Roseville California 95661
Not listed Stanford California 94305
Not listed Torrance California 90502
Not listed Aurora Colorado 80045
Not listed Denver Colorado 80220
Not listed Washington D.C. District of Columbia 20007
Not listed Washington D.C. District of Columbia 20422
Not listed Atlantis Florida 33462
Not listed Clearwater Florida 33756
Not listed Daytona Beach Florida 32117
Not listed Gainesville Florida 32605
Not listed Hudson Florida 34667
Not listed Jacksonville Florida 32209
Not listed Jacksonville Florida 32216
Not listed Miami Florida 33173
Not listed Ocala Florida 34474
Not listed Pensacola Florida 32501
Not listed Safety Harbor Florida 34695
Not listed Tallahassee Florida 32308
Not listed Wellington Florida 33449
Not listed Arlington Heights Illinois 60005
Not listed Elk Grove Village Illinois 60007
Not listed Springfield Illinois 62701
Not listed Springfield Illinois 62702
Not listed Urbana Illinois 61801
Not listed Fort Wayne Indiana 46804
Not listed Fort Wayne Indiana 46845
Not listed Merrillville Indiana 46410
Not listed Iowa City Iowa 52242
Not listed Lexington Kentucky 40536
Not listed Alexandria Louisiana 71301
Not listed Covington Louisiana 70433
Not listed Shreveport Louisiana 71103
Not listed Shreveport Louisiana 71105
Not listed Lewiston Maine 04240
Not listed Baltimore Maryland 21201-1595
Not listed Baltimore Maryland 21218
Not listed Clinton Maryland 20735
Not listed Bay City Michigan 48708
Not listed Dearborn Michigan 48126
Not listed Detroit Michigan 48201
Not listed Lansing Michigan 48912
Not listed Midland Michigan 48670
Not listed Muskegon Michigan 49444
Not listed Wyoming Michigan 49519
Not listed Coon Rapids Minnesota 55433
Not listed Saint Cloud Minnesota 56303
Not listed Jackson Mississippi 39216
Not listed Tupelo Mississippi 38801
Not listed Springfield Missouri 65807
Not listed St Louis Missouri 63128
Not listed Lincoln Nebraska 68506
Not listed Lincoln Nebraska 68510
Not listed Lebanon New Hampshire 03756-0001
Not listed Flemington New Jersey 08822
Not listed Linden New Jersey 07036
Not listed Teaneck New Jersey 07666
Not listed New York New York 10011
Not listed New York New York 10029
Not listed Saratoga Springs New York 12866
Not listed Chapel Hill North Carolina 27517
Not listed Charlotte North Carolina 28204
Not listed Durham North Carolina 27710
Not listed Winston-Salem North Carolina 27103
Not listed Minot North Dakota 58701
Not listed Cincinnati Ohio 45219
Not listed Cincinnati Ohio 45267
Not listed Dayton Ohio 45414
Not listed Springfield Ohio 45505
Not listed Toledo Ohio 43614
Not listed Oklahoma City Oklahoma 73135
Not listed Hillsboro Oregon 97123
Not listed Camp Hill Pennsylvania 17011
Not listed Erie Pennsylvania 16507
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19140
Not listed York Pennsylvania 17405
Not listed Greenville South Carolina 29657
Not listed Rapid City South Dakota 57702
Not listed Knoxville Tennessee 37934
Not listed Amarillo Texas 79106
Not listed Austin Texas 78705
Not listed Dallas Texas 75216-7167
Not listed Dallas Texas 75226
Not listed Edinburg Texas 78539
Not listed Houston Texas 77030
Not listed Humble Texas 77338
Not listed Huntsville Texas 77340
Not listed Kingwood Texas 77339
Not listed San Antonio Texas 78258
Not listed Tyler Texas 75701
Not listed Victoria Texas 77901
Not listed Madison Wisconsin 53713
Not listed Manitowoc Wisconsin 54220
Not listed Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 427 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02504216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02504216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →